Journal of nuclear medicine : official publication, Society of Nuclear Medicine
-
Comparative Study
No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
The purpose of this study was to evaluate the properties of 4-fluoro-3-[131I]iodobenzylguanidine ([131I]FIBG), a potential neuroendocrine tumor and myocardial imaging radiopharmaceutical. ⋯ Iodine-131-FIBG is an analog of MIBG with prolonged binding to neuroblastoma cells in vitro and retention in the myocardium in vivo.